Oral Microencapsulated Diindolylmethane in Treating Patients With Stage II-III Triple Negative, Androgen Receptor Positive Breast Cancer Who Have Undergone Chemotherapy and Surgery
Clinical trial NCT01612910 · WITHDRAWN
Trial details
- NCT number
- NCT01612910
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2014-02-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.